WHO's Human Genome Editing Standards Must Not Impact Somatic Cell Research
Executive Summary
Concerns have been expressed that efforts by the World Health Organization to establish global standards for the whole spectrum of human genome editing research may inadvertently have a negative impact on companies developing somatic cell therapy medicinal products.